Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema
Clinical trial NCT02712008 · COMPLETED
Trial details
- NCT number
- NCT02712008
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-02
- Primary completion
- 2017-07-10
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.